<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-29T21:00:14Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/27139" metadataPrefix="mods">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/27139</identifier><datestamp>2026-02-03T11:00:27Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><mods:mods xmlns:doc="http://www.lyncode.com/xoai" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
   <mods:name>
      <mods:namePart>Gómez-Ramírez, Susana</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Brilli, Elisa</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Tarantino, Germano</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Girelli, Domenico</mods:namePart>
   </mods:name>
   <mods:name>
      <mods:namePart>Muñoz-Gómez, Manuel</mods:namePart>
   </mods:name>
   <mods:extension>
      <mods:dateAvailable encoding="iso8601">2023-06-30T09:32:19Z</mods:dateAvailable>
   </mods:extension>
   <mods:extension>
      <mods:dateAccessioned encoding="iso8601">2023-06-30T09:32:19Z</mods:dateAccessioned>
   </mods:extension>
   <mods:originInfo>
      <mods:dateIssued encoding="iso8601">2023-06-06</mods:dateIssued>
   </mods:originInfo>
   <mods:identifier type="citation">Gómez-Ramírez S, Brilli E, Tarantino G, Girelli D, Muñoz M. Sucrosomial® Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency. Pharmaceuticals. 2023; 16(6):847. https://doi.org/10.3390/ph16060847</mods:identifier>
   <mods:identifier type="uri">https://hdl.handle.net/10630/27139</mods:identifier>
   <mods:identifier type="doi">10.3390/ph16060847</mods:identifier>
   <mods:abstract>Iron deficiency (ID) and iron deficiency anemia (IDA) are highly prevalent worldwide.&#xd;
Oral iron salts, especially ferrous sulfate, are commonly used for the treatment of iron deficiency (ID).&#xd;
However, its use is associated with gastrointestinal side effects, thus compromising treatment com pliance. Intravenous iron administration is a more costly and logistically complex alternative and&#xd;
is not risk-free, as infusion and hypersensitivity reactions may occur. Sucrosomial® iron is an oral&#xd;
formulation consisting of ferric pyrophosphate conveyed by a phospholipid and sucrester matrix&#xd;
(sucrosome®). Intestinal Sucrosomial® iron absorption is mediated by enterocytes and M cells,&#xd;
through the paracellular and transcellular routes, and occurs mostly as intact particles. These phar macokinetic properties of Sucrosomial® iron result in higher iron intestinal absorption and excellent&#xd;
gastrointestinal tolerance compared to oral iron salts. The evidence derived from clinical studies&#xd;
supports the use of Sucrosomial® iron as a valid first option for the treatment of ID and IDA, espe cially for subjects who are intolerant or refractory to conventional iron salts. Newer evidence also&#xd;
demonstrates the effectiveness of Sucrosomial® iron, with a lower cost and fewer side effects, in&#xd;
certain conditions usually treated with IV iron in current clinical practice</mods:abstract>
   <mods:language>
      <mods:languageTerm>eng</mods:languageTerm>
   </mods:language>
   <mods:accessCondition type="useAndReproduction">http://creativecommons.org/licenses/by/4.0/</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">open access</mods:accessCondition>
   <mods:accessCondition type="useAndReproduction">Atribución 4.0 Internacional</mods:accessCondition>
   <mods:subject>
      <mods:topic>Anemia - Tratamiento</mods:topic>
   </mods:subject>
   <mods:subject>
      <mods:topic>Hierro - Uso terapéutico - Ensayos</mods:topic>
   </mods:subject>
   <mods:titleInfo>
      <mods:title>Sucrosomial® Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency.</mods:title>
   </mods:titleInfo>
   <mods:genre>journal article</mods:genre>
</mods:mods>
</metadata></record></GetRecord></OAI-PMH>